ArticleJournal of vascular surgery. Venous and lymphatic disorders2026
How patient profile and hospital setting drive pulmonary embolism treatment modality.
Article in Journal of vascular surgery. Venous and lymphatic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate how the choice of intervention modality for pulmonary embolism (PE) is influenced by patient and hospital characteristics. We compared catheter-directed thrombolysis (CDT), percutaneous mechanical thrombectomy (PMT), and surgical embolectomy.
methodsUtilizing the Maryland statewide database from the Health Services Cost Review Commission (HSCRC), we analyzed interventions for PE over a 6-year period (fiscal years 2019-2024), focusing on CDT, PMT, and surgical embolectomy. Key hospital factors, including trauma center status, hospital size, Leapfrog safety ratings, extracorporeal membrane oxygenation (ECMO) availability, and PE volume, were assessed for their association with intervention choice. Patient characteristics were assessed for their association with intervention choice including demographics, comorbidities, and health insurance status. Univariate and multivariate statistics were performed to assess the relationship between patient and hospital characteristics and PE interventions.
resultsOver time the utilization of PMT increased with a concomitant decrease in utilization of CDT. CDT was more commonly performed in trauma centers, smaller hospitals, Leapfrog B to D rated hospitals, and hospitals with lower PE volumes. In contrast, PMT was more frequently performed in non-trauma centers, non-ECMO programs, larger hospitals, Leapfrog A rated hospitals, and hospitals with higher PE volumes. Surgical embolectomy was primarily performed in high-volume centers equipped with cardiac surgery and ECMO capabilities. African American patients and those with higher social vulnerability index were more likely to undergo CDT. Comorbidity profiles increased progressively from CDT to PMT to surgical embolectomy. Surgical embolectomy patients were generally younger and more likely to be on Medicaid, whereas PMT/CDT patients were more commonly covered by Medicare. Patients undergoing surgery had higher rates of transfer from other facilities. There were no significant differences in rates of non-routine discharge or mortality across the interventions. In the multivariate model, presence of a cardiac surgery program was associated with increased odds of PMT.
conclusionsPMT has been adopted at a higher rate than CDT in Maryland over the past 6 years, potentially due to benefits such as reduced length of stay and intensive care unit requirements. Our findings demonstrate that both patient and hospital characteristics influence the modality of PE intervention. These results highlight significant disparities based on race, social vulnerability, and hospital characteristics that warrant systemic attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.